Jinyun laser received the supervision letter: due to relevant connected transactions, the review procedures and letter Phi obligations were not performed in time
Cailian, September 22 (Xinhua) the board of directors of Jinyun laser received the supervision letter and failed to timely perform the review procedures and information disclosure obligations in accordance with the related party transactions due to the following matters: in June 2021, Jinyun interactive, a wholly-owned subsidiary of the company, signed the equity investment agreement with Jinyun co creation and Yao Peng, and jointly invested in the establishment of Beijing jikehui game. The above joint investment belongs to related party transactions. However, the company did not timely perform the review procedures and information disclosure obligations in accordance with the related party transactions, and did not hold a meeting of the board of directors for supplementary review until August 27, 2021, and performed the information disclosure obligations.
This text is a result of machine translation.
Related companies：
Briefing Yesterday 08:05 PM
· Healthcare
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Updated 28 mins ago
· Technology
US Treasury Secretary: the US government's seizure of frozen assets of the Russian central bank is "illegal"
Briefing Jan 14, 2022 01:18 PM
· Healthcare
Mask protection unit rose in the afternoon
May 02, 2022 07:50 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Apr 18, 2022 09:14 PM
Briefing Jan 05, 2022 09:49 PM
· Healthcare
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Briefing Nov 01, 2021 07:34 PM
· Healthcare
Robust medical: by the end of October, 1159400 shares had been repurchased
Healthcare
Nucleic Acid Drug CDMO Olipharma Raises Tens of Mns of CNY in Pre-Series A Round
As a new way to treat diseases, gene therapy has higher R&D investment and risk than biochemical drugs. Both pharmaceutical giants and start-ups tend to collaborate with outsourcing service providers, which brings business opportunities to cell and gene therapy contract development and manufacturing organizations (CDMOs).
Yesterday 09:59 PM
Briefing Aug 03, 2021 02:55 PM
· Healthcare
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
Briefing Jul 22, 2021 07:33 PM
· Healthcare
Xinxiang Chemical Fiber: some production workshops of viscose filament are temporarily shut down due to water inflow
Technology
China Satellite Navigation and Location Services Industry Reached CNY 469 Billion
According to the GNSS and LBS Association of China's White Paper on the Development of China's Satellite Navigation and Location Services Industry (2022), China's Satellite Navigation and Location Services Industry grew by 16.29 % year over year, reaching CNY 469 billion.
Yesterday 06:56 PM
Briefing Updated 1 hour ago
· Financials
The main capital continued to flow into 57 shares for more than 5 consecutive days
Briefing Updated 1 hour ago
· Technology
Russia may cut off gas supplies to Finland this week
See more
Read next
In-depth
In-depth
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.